BioPortfolio Limited
Pain Therapeutics 2005: Market Dynamics and Outlook Table of Contents 1 Methodology and Executive Summary 1.1 Report Objectives and Scope 1.2 Research Methodology 1.3 Executive Summary 2 Causes, Classifications and Global Impact of Pain 2.1 Causes 2.1.1 Terminal Illness 2.1.2 Pain and Genetics 2.1.3 The Immune System and Pain 2.1.4 The Subjective Nature of Pain 2.1.5 Pain...
BioPortfolio Limited
92 Endo 94 Strategies for success 96 Pain prevention 96 Drug delivery formulations/reformulations 99 Oral delivery formulations 100 Intravenous delivery formulations 101 Transmucosal delivery formulations 102 Transdermal delivery formulations 102 Key drug delivery strategies in the pain market 103 Depression and pain relief 105 CHAPTER 5 OPIOID DRUGS LATE-STAGE DRUG ANALYSIS &...
Baxter s Products & Services Directory page 14
author: Center for One Baxter
subject: For questions about our Products and Services
duplicates:http://www.baxter.com/customers/products_svcs/2003_products_and_services_directory.pdf
Baxter s Products & Services Directory
Tablets MESNEX* (MESNA) Product Information: Bristol Myers- Squibb Medical Services 800- 426- 7644 ALFENTANIL HYDROCHLORIDE INJECTION ATIVAN (LORAZEPAM) INJECTION AMIODARONE HYDROCHLORIDE INJECTION ATRACURIUM BESYLATE INJECTION ATROPINE SULFATE INJECTION, USP BUMETANIDE INJECTION BUTORPHANOL TARTRATE INJECTION, USP CISplatin INJECTION DILTIAZEM HCI INJECTION DOBUTAMINE...
author: Center for One Baxter
subject: For questions about our Products and Services
Midazolam Hydrochloride Injection page 2
author: Baxter Healthcare Corporation
Midazolam Hydrochloride Injection page 1
author: Baxter Healthcare Corporation
Midazolam Hydrochloride Injection
Midazolam Hydrochloride Injection CIV Rx only WARNING Adult and Pediatric Intravenous midazolam HCl has been associated with respiratory depression and respiratory arrest, especially when used for sedation in noncritical care settings. Severe hypotension and seizures have been reported following rapid IV administration, particularly with concomitant use of fentanyl ...
author: Baxter Healthcare Corporation
Products in Development - Endo Pharmaceuticals
and Canadian marketing and distribution rights licensed from SkyePharma, Inc.) Induction and/or maintenance of anesthesia Phase III Frova ® (frovatriptan) Long-acting triptan (selective serotonin receptor agonist) (Exclusive North American marketing rights licensed from Vernalis Development Limited) Prophylaxis for menstrually associated migraine Phase III Lidoderm ® ...
Products in Development - Endo Pharmaceuticals
and Canadian marketing and distribution rights licensed from SkyePharma, Inc.) Induction and/or maintenance of anesthesia Phase III Frova ® (frovatriptan) Long-acting triptan (selective serotonin receptor agonist) (Exclusive North American marketing rights licensed from Vernalis Development Limited) Prophylaxis for menstrually associated migraine Phase III Lidoderm ® ...
BioPortfolio Limited
8.5 Diagnosis of Neuropathy 8.6 The Classifications of Neuropathy 8.6.1 Diabetic Neuropathy 8.6.2 Auto-Immune Disease Related and its Relationship with Neuropathic Pain 8.6.3 Chemotherapy-Induced Neuropathy 8.6.4 Drug-Related Neuropathy 8.7 The Societal Impact of Neuropathy 8.8 The Cost of Neuropathic Pain Table 8.1 The Annual Cost of Pain 8.9 Current Treatment of Neuropathy 8.10 Non...
Covance: Services & Products: CHEOS: Publications
Selected Publications 2003 Ackerman SJ, Knight T, Schein J, Carter C, Staats P Risk of constipation in patients prescribed fentanyl transdermal system or oxycodone hydrochloride controlled-release in a California Medicaid population Patient-reported utilization patterns of fentanyl transdermal system and oxycodone hydrochloride controlled-release among patients with...
Drug Approvals - D
ANDA 75-371 8/27/99 9/2/99 - - Dacarbazine for Injection USP, 200 mg/vial, Rx Gensia Sicor Pharmaceuticals ANDA 75-259 8/27/98 9/2/98 - - Dalmane (flurazepam hydrochloride) Capsules, 15 mg and 30 mg ICN Pharmaceuticals NDA 16-721/S-074 6/14/01 11/22/02 Daraprim (pyrimethamine) Tablets, 25 mg, Rx GlaxoSmithKline NDA 8-578/S16 11/18/03 11/25/03 12/1/03 - Daraprim (pyrimethamine)...
Drug Approvals - A
Actigall (ursodiol) Capsules,- Novartis Pharmaceuticals Corporation NDA 19-594/S-021 8/14/02 8/21/02 - - Actiq (oral transmucosal fentanyl citrate), Rx ( Consumer Safety Alert ) Cephalon, Inc NDA 20-747/S11 6/10/02 6/17/02 - - Actiq (oral transmucosal fentanyl citrate), Rx Anesta Corporation NDA 20-747/S10 3/7/02 3/12/02 - - Actiq (oral transmucosal fentanyl ...
1996 and Older - New Drug Application (NDA)
New Drug Approval Packages These drug approval packages, sorted by product trade name, are supplied by the CDER Freedom of Electronic Information Office 19546 12/20/1990 9/10/2002 Exidine Chlorhexidine Gluconate Xttrium 19125/S28 06/06/1996 9/11/2003 Fentanyl Oralet (oral transmucosal fentanyl citrate) [649 KB] Anesta Corp 20195/S-002 5/20/96 8/2/99 Fragmin...
Paragraph IV Patent Certifications
- DRUG NAME DOSAGE FORM STRENGTH RLD Acetaminophen Extended-release Tablets 650 mg Tylenol Acetaminophen/ Aspirin/ Caffeine Tablets 250 mg/250 mg/ 65 mg Excedrin (migraine) Acetaminophen and Tramadol Hydrochloride Tablets 325 mg/ 37.5 mg Ultracet Acyclovir Sodium1 Injection 50 mg/mL, 10 mL and 20 mL vials Zovirax Albuterol Sulfate Oral Syrup 2 mg(base)/ 5 mL Ventolin Albuterol...
http://www.fda.gov/cder/orange/appendix_a.txt
3, ACETAMINOPHEN ACETAMINOPHEN W/ CODEINE PHOSPHATE #3, ACETAMINOPHEN ACETAMINOPHEN W/ CODEINE PHOSPHATE, ACETAMINOPHEN ACETAMINOPHEN W/ CODEINE, ACETAMINOPHEN ACETAMINOPHEN, ACETAMINOPHEN (OTC) ACETAMINOPHEN, ASPIRIN AND CAFFEINE, ACETAMINOPHEN (OTC) ACETAMINOPHEN, ASPIRIN, AND CODEINE PHOSPHATE, ACETAMINOPHEN ACETAMINOPHEN, BUTALBITAL AND CAFFEINE, ACETAMINOPHEN ACETAMINOPHEN,...
EFFICACY SUPPLEMENTS APPROVED IN CALENDAR YEAR 2003
FENTANYL ALZA 19-813 SE1 036 26-Nov-02 20-May-03 Y 5.8 Provides for the use of Duragesic (Fentanyl Transdermal System) in opioid-telerant pediatric patients 2 years of age and older *Supplement Type Description for SE1 - SE7 N (Chemical Type 6) SE1 SE2 SE3 SE4 SE5 SE6 SE7 NDA Type 6 - New Indication New or modified indication New dosage regimen New route of...
http://www.fda.gov/cder/dmf/text/4Q2003ACTIVETYPE2TEXT.txt
"LOTEPREDNOL ETABONATE MANUFACTURED IN ARVILLE CEDEX, FRANCE." 11106 30-Sep-94 3M PHARMACEUTICALS INC "CHLOROFLUOROCARBON PROPELLANT P-11 (TRICHLOROFLUOROMETHANE, NF) MANUFACTURED IN BY ELF ATOCHEM IN VIZCAYA, SPAIN" 11107 30-Sep-94 3M PHARMACEUTICALS INC "CHLOROFLUOROCARBON PROPELLANT P-12 (DICHLOROFLUOROMETHANE,NF) MANUFACTURED BY ELF ATOCHEM IN VIZCAYA,SPAIN." 11108 30-Sep-94 3M...
http://www.fda.gov/cder/dmf/xls/4Q2003ACTIVETYPE2EXCEL.xls
82 KNOLL AG LUDWIGSHAFEN CAFFEINE (HYDROUS, ANHYDROUS FORMS) DEGUSSA AG L-ARGININE ACETATE AS PRODUCED BY REXIM S.A.DIV DEGUSSA -HAM FRANCE JOHNSON MATTHEY PLC BULK FENTANYL CITRATE MANUF METFORMIN HYDROCHLORIDE (LA 6023) BOEHRINGER INGELHEIM CHEMICALS INC METHOCARBAMOL ESTEVE QUIMICA SA ALPHA METHYLDOPA SARTORIUS FILTERS INC FILTER MEMBRANE MATERIALS MANUFACTURED AT...
OGD Suitability Tracking Reports (Sorted by Petition Number) as of 1/5/2004
- TABLET; ORAL Approved 2/28/2003- BACLOFEN 10 mg, 20 mg - 02P-0078/CP1 KLEINFELD, KAPLAN & BECKER - ORALLY DISINTEGRATING TABLETS Approved 2/5/2003- OXYCODONE 5mg, 7.5mg, 10mg ACETAMINOPHEN 300mg - 02P-0105/CP1 LACHMAN CONSULTANT SERVICES - TABLETS Approved 8/6/2002- CARISOPRODOL 350 mg - 02P-0138/CP1 LACHMAN CONSULTANT SERVICES - ORALLY DISINTEGRATING TABLETS Withdrawn 7/25/2002-...
OGD Suitability Tracking Reports (Sorted by Drug Name) as of 1/5/2004
- INJECTION Approved 8/13/2003- ESTROPIPATE 1.2 mg - 02P-0141/CP1 WOMEN FIRST HEALTHCARE - TABLETS Approved 9/24/2002- ETHINYL ESTRADIOL 0.035 MG NORETHINDRONE 0.4 MG - 99P-1150/CP1 KIRKLAND & ELLIS - TABLET; CHEWABLE Approved 4/14/2000- FAMOTIDINE 10MG - 00P-1422/CP1 YAMANOUCHI PHARMA TECHNOLOGIES - TABLET; ORALLY DISINTEGRATING Approved 4/17/2001- FENOFIBRATE 107 mg - 02P-0148/CP1...
Prescription and Over-the-Counter Drug Product List: 11/2003
ACTHAR GEL >D> BC + QUESTCOR PHARMS 80 UNITS/ML N08372 008 NOV CTEC >A> + 80 UNITS/ML N08372 008 NOV CTEC CYTARABINE INJECTABLE; INJECTION >D> CYTARABINE >D> AP + GENSIA SICOR PHARMS 100MG/VIAL N16793 001 NOV DISC >D> AP + 500MG/VIAL N16793 002 NOV DISC >D> AP + 1GM/VIAL N16793 003 DEC 21, 1987 NOV DISC >D> AP + 2GM/VIAL N16793 004 DEC 21, 1987 NOV DISC >A> @ SICOR PHARMS 100MG/VIAL...
http://www.paddocklabs.com/forms/secundum/volume_9_2.pdf
Rx Fentanyl 100 µg/ 0.1 mL and Promethazine HCl 12.5 mg/ 0.1 mL in PLO Fentanyl citrate 157 mg (equiv to 100 mg of fentanyl) Promethazine HCl 12.5 g Ethoxy diglycol 10 mL Lecithin/ Isopropyl palmitate 22 mL Pluronic F127 30% gel qs 100 mL Combine the fentanyl citrate and promethazine hydrochloride with the ethoxy diglycol Rx Fentanyl 35 µg/...
http://www.paddocklabs.com/forms/secundum/volume_9_2.pdf page 4
996PaddockSec.qxd
Secundum Artem VOLUME 10 NUMBER 4 Current & Practical Compounding Information for the Pharmacist Very often, the resistance decreases during a procedure; as a result the current, in milliamps, will increase Quality Control: Theoretical yield compared with actual yield, physical observation, pH, sterility tests (0.001- 0.01%), calcium chloride (2%), sodium chloride (2%),...
author: SilverStreak